The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Seropositive Rheumatoid Arthritis Drug Market Research, Growth Opportunities, Analysis and Forecasts Report 2020-2026on November 24, 2020 at 2:35 am
The report “ Seropositive Rheumatoid Arthritis Drug Market ” in Global to 2026 - Market Scope, Development, and Predictions offers the most up-to-date industry information on the actual market ...
- Small Molecule Therapies for Rheumatoid Arthritis Market Research Study including Growth Factors, Types and Application by regions from 2020 to 2025on November 23, 2020 at 6:32 am
Nov 23, 2020 (Heraldkeepers) -- Increasing ageing population and healthcare expenditure will expand the small molecule therapies for rheumatoid arthritis market size over the forecast time line.
- FDA gives emergency approval for rheumatoid arthritis drug and remdesivir as COVID-19 treatmenton November 19, 2020 at 4:00 pm
The Food and Drug Administration on Thursday issued emergency approval for a rheumatoid arthritis drug in combination with the antiviral medication remdesivir as a treatment for hospitalized adults ...
- FDA Approves Remdesivir, Rheumatoid Arthritis Drug to Treat Hospitalized COVID Patientson November 19, 2020 at 3:24 pm
The FDA issued an emergency use authorization on Thursday for the combination of remdesivir with a rheumatoid arthritis drug, baricitinib, to treat moderate to severe hospitalized COVID-19 patients.
- Rheumatoid arthritis drug appears to help Covid patients in ICUon November 19, 2020 at 8:31 am
A drug used to treat rheumatoid arthritis appears to help patients who are admitted to intensive care with the most severe coronavirus infections, researchers say. Tocilizumab, a medicine that dampens ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Anti-Rheumatics Market to Witness Huge Growth from 2019 – 2026 and Key Players – Pfizer, Johnson & Johnsons, Bristol-Myers Squibbon November 25, 2020 at 12:11 am
Anti-rheumatics market accounted for $57,229 million in 2018 and is expected to reach $71,934 million by 2026, registering a CAGR of 2.9% from 2019 to 2026. Rheumatoid arthritis (RA) is a chronic auto ...
- European Commission Approves Janssen’s TREMFYA® (guselkumab), a First-in-Class Treatment for Active Psoriatic Arthritis (PsA)on November 24, 2020 at 11:00 pm
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the European Commission (EC) has approved TREMFYA ® ▼ (guselkumab) for the treatment of adult patients with active ...
- NXT USA launches novel joint health formula called TamaFlexon November 24, 2020 at 4:07 pm
According to the firm, TamaFlex targets two pathway that cause joint inflammation: COX-2 and 5-LOX enzyme pathways. It also contains the first tamarind seed extract available globally to be backed by ...
- 7 Reasons to Integrate CBD into Your Fitness Routineon November 24, 2020 at 8:43 am
This article will look into the seven unique ways CBD can help reach your fitness goal. Exercising makes you feel strong and resilient. However, after a while, the repeating movements make your ...
- Alvotech, Alvotech & CCHT Biopharmaceutical and Yangtze River Pharmaceutical Agree on an Exclusive Biosimilar Partnership in Chinaon November 24, 2020 at 6:00 am
Alvogen enters into an exclusive strategic partnership agreement for the commercialization of eight biosimilar medicines in China.